The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 03, 2018

Filed:

May. 09, 2017
Applicant:

Advanced Cancer Therapeutics, Llc, Louisville, KY (US);

Inventors:

Gilles H. Tapolsky, Louisville, KY (US);

Pooran Chand, Birmingham, AL (US);

Assignee:

GB ACT, INC., San Diego, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/00 (2006.01); A61K 31/724 (2006.01); A61K 31/5377 (2006.01); A61K 31/4709 (2006.01); C07D 401/06 (2006.01); A61K 45/06 (2006.01); A61K 9/08 (2006.01); A61K 9/19 (2006.01); A61K 47/26 (2006.01); A61K 47/40 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4709 (2013.01); A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 31/00 (2013.01); A61K 45/06 (2013.01); A61K 47/26 (2013.01); A61K 47/40 (2013.01); C07D 401/06 (2013.01);
Abstract

A novel compound, (E)-1-(pyridyn-4-yl)-3-(7-(trifluoromethyl)quinolin-2-yl)-prop-2-en-1-one, is provided herein. (E)-1-(pyridyn-4-yl)-3-(7-(trifluoromethyl)quinolin-2-yl)-prop-2-en-1-one is an inhibitor of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) with surprisingly superior efficacy and pharmacodynamic properties in vitro and in vivo. Also provided are pharmaceutical compositions including the compound and methods of use of the compound in treating cancer and tumors in vivo, as well as inhibiting glycolytic flux and PFKFB3 enzymatic activity in cells.


Find Patent Forward Citations

Loading…